CRA was retained by the plaintiff in a patent dispute to determine the amount of reasonable royalties due as a result of infringement of a patent by a major medical device company. CRA’s intellectual property expert evaluated the economic and technological comparability of multiple license agreements, the feasibility of non-infringing alternatives, and the Georgia-Pacific factors to determine the appropriate reasonable royalty rate. Dr. Sean Sheridan submitted an expert report and provided testimony in deposition. The case settled prior to trial.
An economic analysis of the artificial intelligence-copyright nexus
Among the large number of policy issues that are raised by the introduction and expanded use of Artificial Intelligence (“AI”) – its potential for the creation...